With all the bad-blood regarding the medical device tax, it may be hard to imagine that there are actually aspects of the Affordable Care Act (aka Obamacare) that actually bode well for medical technology firms.
Here is a slideshow of four areas of opportunity for medtech firms under Obamacare. They are based on expert opinion from Patrick Hurd, attorney at LeClairRyan; Frederick Brown, healthcare practice managing director for Ducker Worldwide; and a report from Danielle Antalffy, research analyst at healthcare investment bank Leerink Swann.
Demand for Elective Procedures Will Likely Rise
[Photo Credit: iStockPhoto.com]
|Learn more about how Obamacare is affecting next-generation medical technologies in a conference session at MEDevice San Diego, on September 26, 2013.|